Publikationen (49) Publikationen, an denen Forscher/innen teilgenommen haben

2004

  1. A single prior course of BCNU-cisplatin chemotherapy has a significant deleterious effect on mobilization kinetics of otherwise untreated patients

    Bone Marrow Transplantation, Vol. 33, Núm. 5, pp. 499-502

  2. Alternativas farmacológicas a la transfusión sanguínea. ¿Qué hay de nuevo?

    Medicina Clinica, Vol. 122, Núm. 6, pp. 231-236

  3. Angiogénesis y cáncer colorrectal: Papel predictivo y pronóstico del factor de crecimiento del endotelio vascular

    Medicina Clinica

  4. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty

    International Journal of Cardiology, Vol. 95, Núm. SUPPL. 1

  5. Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: The GEL/TAMO experience

    Annals of Oncology, Vol. 15, Núm. 10, pp. 1504-1509

  6. Cellular cardiomyoplasty: Clinical application

    Annals of Thoracic Surgery, Vol. 77, Núm. 3, pp. 1121-1130

  7. Chromosomal abnormalities clustering in multiple myeloma reveals cytogenetic subgroups with nonramdom acquisition of chromosomal changes [6]

    Leukemia

  8. Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: Two further cases

    Hematology Journal, Vol. 5, Núm. 6, pp. 534-537

  9. Controversy over the benefits of pulsatile perfusion (multiple letters) [1]

    International Journal of Artificial Organs

  10. Correlation between thrombus regression and recurrent venous thromboembolism. Examining venographic and clinical effects of low-molecular-weight heparins: A meta-analysis

    Journal of Thrombosis and Haemostasis, Vol. 2, Núm. 9, pp. 1581-1587

  11. Cryptic ins(2;11) with clonal evolution showing amplification of 11q23-q25 either on hsr(11) or on dmin, in a patient with AML-M2 [4]

    Leukemia

  12. Células madre adultas: fuentes, características y perspectivas sobre su uso terapeútico

    Monografías Humanitas, Núm. 4, pp. 7-22

  13. Efficient transfection of embryonic and adult stem cells

    Stem Cells, Vol. 22, Núm. 4, pp. 531-543

  14. El sistema hemostático en los síndromes coronarios agudos: Implicaciones fisiopatológicas y terapéuticas

    Revista Clinica Espanola, Vol. 204, Núm. 4, pp. 221-227

  15. Estados trombofílicos: implicaciones clínicas, diagnóstico y tratamiento

    Fisiopatología de las enfermedades cutáneas IV (Aula Médica Ediciones), pp. 369-389

  16. G-CSF or not G-CSF? That is the question [1]

    Bone Marrow Transplantation

  17. Imatinib Inhibits Proliferation of Ewing Tumor Cells Mediated by the Stem Cell Factor/KIT Receptor Pathway, and Sensitizes Cells to Vincristine and Doxorubicin-Induced Apoptosis

    Clinical Cancer Research, Vol. 10, Núm. 2, pp. 751-761

  18. Imatinib mesylate in cutaneous melanoma [7]

    Journal of Investigative Dermatology

  19. In vivo blockade of pemphigus vulgaris acantholysis by inhibition of intracellular signal transduction cascades

    British Journal of Dermatology, Vol. 151, Núm. 3, pp. 565-570

  20. Indicaciones y valoración clínica de las pruebas analíticas de hemostasia

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 9, Núm. 22, pp. 1442-1445